16
Tue, Jul
72 New Articles

During the last decade, Albania has undertaken several initiatives to liberalize the electric energy sector and increase local generation capacities. Such measures have created a lively market, especially in the renewal energy segment.

It has been over a year since the European Union’s General Data Protection Regulation became mandatory across Europe, marking a seismic shift in the way that companies collect, process, and handle personal data. Countries across the European Union and beyond have adapted their national laws to meet the requirements of the GDPR – with many introducing local derogations as permitted by the GDPR.

Emmanuel Kaufman has a unique profile: An Argentinian lawyer and commercial and international investment arbitration specialist who has spent the last 12 years in two of the leading law firms in Austria. He has spent the last three and a half years as a partner at Knoetzl, where he focuses on complex arbitration proceedings in the construction, telecommunications, IT, gaming, and soft-beverages industries.

Earlier this year, CEE Legal Matters reported that Herbst Kinsky Rechtsanwalte had advised Marinomed Biotech AG on its February 1, 2019 debut on the Vienna Stock Exchance, with Weber & Co. advising Erste Group Bank AG (as sole global coordinator) and Goetzpartners Securities Ltd (as co-lead manager) on the IPO. Marinomed’s was the first successful IPO in Austria since BAWAG’s in 2017.

“Where do you see yourself in 5 or 10 years?” the Cravath partner in New York asked after fifteen or so minutes, thereby signaling that the interview was coming to an end, expecting to hear the standard reply emphasizing the applicant’s desire to work hard if offered the position. “Home,” I replied. “In Albania.”

The fiscal aspects of the hydrocarbon sector in Albania will be soon governed by a new law. The new draft “On the Fiscal Regime for Petroleum Operations” law (the “New Draft Law”) was initially published in the Electronic Register of Public Announcement and Consultations on April 4, 2019 and has been circulated for comment among stakeholders, chambers of commerce, and experts’ associations in Albania.

“Where do you see yourself in 5 or 10 years?” the Cravath partner in New York asked after fifteen or so minutes, thereby signaling that the interview was coming to an end, expecting to hear the standard reply emphasizing the applicant’s desire to work hard if offered the position. “Home,” I replied. “In Albania.”

Under Austrian law, incorrect land register entries may trigger public liability. But the Austrian Supreme Court recently held that such incorrect entries only create public liability claims for of a certain group of people, thereby potentially increasing the risk management costs of mortgage-backed loans.

There are two interesting developments on the Austrian legal market: First, Legal Tech and Digitalization initiatives are on the rise. Second, the Top 20 law firms in Austria have increased their revenue last year, and the legal business is flourishing.

Sponsors of the 2020 Dealer’s Choice Law Firm Summit, which will be held on April 23, 2020 in conjunction with the Deal of the Year Awards Banquet, explain their involvement.

When it first appeared, the compliance field seemed little more than “regulatory” in new clothes – a fancy name for making sure a company stayed within the ambit of provisions set out in the laws of a country. As time passed, however, more and more companies started treating compliance as a practice in its own right, and as a field of law … that is much more than just law. Compliance became an area of interest not only to seasoned lawyers, but also to scholars, consultants, and in-house counsels – all levels of legal practice became aware of its significance.

How do law firms in Austria promote themselves to current and prospective employees? A series of conversations with several leading firms revealed more than expected.

This time, our law firm marketing friends across CEE considered the following question: “What one part of your job would you most appreciate having more help with – not in terms of training or capability, but simply in terms of time?”

I am often asked by my foreign colleagues and clients about how the Czech Republic is doing, and my answer is that we are doing fine. Putting aside the political situation, which is similar to many other countries, economically we are doing very well; there was strong GDP growth of 4.6% in 2017 and almost 3% last year. Part of this growth is clearly attributable to our strong, maturing startup and investor community, which is pushing the country forward. Czechs have a talent for improvisation and finding solutions that work well, using innovation, research and development, and technology. We have invented many tools that have changed the world in fields such as nanotechnology, chemistry, and engineering. At the same time, we now have a pool of investors who are able to invest in new startup companies and back up the research and development that is done.

The enforcement of pharmaceutical patent rights in Russia is a multi-aspect issue. One such aspect, well known to the industry and patent owners, is the attempt to prevent pharmaceuticals that may infringe on prior patent rights from being registered by the Russian healthcare authorities.

In late 2018, the Competition Council of the Republic of Latvia published the final report on its most recent in-depth sector inquiry on the distribution practices of reimbursed medicines on the wholesale market and potential competition restrictions therein. The sector inquiry had lasted for almost two years, during which the Competition Council gathered information from both the public and the private sectors, approaching seven producers, twelve wholesalers, and several public institutions, such as the State Agency of Medicines and the Health Inspectorate, among others. Although the Competition Council proclaimed that the main goal of the sector inquiry was to analyze potential competition restrictions on the wholesale market, which could be apparent because of the vertical integration of wholesalers and leading pharmacy chains and the exclusivity status of the wholesalers, no infringements proceedings were initiated as a result. Notwithstanding the lack of subsequent infringement proceedings, however, some crucial conclusions were drawn.

Page 1 of 2

Our Latest Issue